Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Psychopharmacology

• Publication date

  2008-07-24

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-008-1237-1PMID 18649072
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of return

  2008cited by this paper
• CO-PLANAR STEREOTAXIC ATLAS OF THE HUMAN BRAIN 3-DIMENSIONAL PROPORTIONAL SYSTEM: AN APPROACH TO CEREBRAL IMAGING 1988 GUIDE TO THE TNM/pTNM-CLASSIFICATION OF MALIGNANT TUMOURS THIRD EDITION

  2007cited by this paper
• Temporal Dynamics of the Attentional Spotlight: Neuronal Correlates of Attentional Capture and Inhibition of Return in Early Visual Cortex

  2007influential reference
• Orienting of attention in unmedicated patients with schizophrenia, prodromal subjects and healthy relatives.

  2007cited by this paper
• Deficient inhibition of return in schizophrenia-further evidence from an independent sample.

  2006influential reference
• WC1C DEVELOPMENT AND EVALUATION OF THE SCHIZOPHRENIA PRONENESS INSTRUMENT, ADULT VERSION (SPI-A)

  2006cited by this paper
• Inhibition of Return in the Human 5HT2A Agonist and NMDA Antagonist Model of Psychosis

  2006influential reference
• Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia

  2006cited by this paper
• Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study

  2005cited by this paper
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

  2005cited by this paper
• Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers

  2005influential reference
• Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval task

  2005cited by this paper
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

  2005cited by this paper
• NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.

  2005influential reference
• Acute Ketamine Administration Alters the Brain Responses to Executive Demands in a Verbal Working Memory Task: an fMRI Study

  2004cited by this paper
• Blunted inhibition of return in schizophrenia-evidence from a longitudinal study.

  2004cited by this paper
• Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia.

  2004cited by this paper
• Neural correlates of the automatic and goal-driven biases in orienting spatial attention.

  2004cited by this paper
• Neural networks underlying endogenous and exogenous visual-spatial orienting

  2004influential reference
• An Event-related fMRI Study of Exogenous Orienting: Supporting Evidence for the Cortical Basis of Inhibition of Return?

  2004cited by this paper
• Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity

  2004cited by this paper
• Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

  2003cited by this paper
• Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modeling

  2003cited by this paper
• Ketamine and fMRI BOLD signal: Distinguishing between effects mediated by change in blood flow versus change in cognitive state

  2003cited by this paper
• The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice

  2003cited by this paper
• Glutamatergic mechanisms in schizophrenia.

  2003cited by this paper
• Delayed onset of inhibition of return in schizophrenia.

  2002influential reference
• Covert Reorienting and Inhibition of Return: An Event-Related fMRI Study

  2002influential reference
• NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors—implications for models of schizophrenia

  2002cited by this paper
• Evidence for abnormal cortical functional connectivity during working memory in schizophrenia.

  2001cited by this paper
• Attentional asymmetry in schizophrenia: disengagement and inhibition of return deficits.

  2001influential reference
• Prefrontal neurons and the genetics of schizophrenia.

  2001cited by this paper
• Inhibition of return.

  2000cited by this paper
• Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

  2000cited by this paper
• The schizophrenia ketamine challenge study debate.

  1999cited by this paper
• Spatial and semantic inhibitory processing in schizophrenia.

  1999cited by this paper
• Evidence relating human verbal memory to hippocampal N-methyl-D-aspartate receptors.

  1999cited by this paper
• Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDG

  1999cited by this paper
• Symptom provocation studies in psychiatric disorders: scientific value, risks, and future.

  1999cited by this paper
• Neural Basis of Endogenous and Exogenous Spatial Orienting: A Functional MRI Study

  1999influential reference
• Inhibition of return in spatial attention: direct evidence for collicular generation

  1999cited by this paper
• Inhibitory processing in visuospatial attention in healthy adults and schizophrenic patients.

  1999cited by this paper
• Covert visual attention in patients with early-onset schizophrenia.

  1998cited by this paper
• The NMDA antagonist model for schizophrenia: promise and pitfalls.

  1998cited by this paper
• Visual attention and symptoms in schizophrenia: a 1-year follow-up.

  1998cited by this paper
• History, rationale and potential of human experimental hallucinogenic drug research in psychiatry.

  1998cited by this paper
• Saccadic and attentional abnormalities in patients with schizophrenia

  1998cited by this paper
• Distinguishing schizophrenic patients from healthy controls by quantitative measurement of eye movement parameters.

  1998cited by this paper
• History, Rationale and Potential of Human Experimental Hallucinogenic Drug Research in Psychiatry

  1998cited by this paper
• Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

  1997cited by this paper
• Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET).

  1997cited by this paper
• Visualisation of changes in regional cerebral blood flow (rCBF) produced by ketamine using long TE gradient-echo sequences: preliminary results.

  1995cited by this paper
• Antisaccades and smooth pursuit eye movements in schizophrenia.

  1995cited by this paper
• DSM-IV: Diagnostic and Statistical Manual of Mental Disorders

  1994cited by this paper
• Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

  1994cited by this paper
• Attentional asymmetry in schizophrenia: the role of illness subtype and symptomatology.

  1994influential reference
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994cited by this paper
• Abnormalities in rapid, automatic aspects of attention in schizophrenia: blunted inhibition of return.

  1994influential reference
• Deficits of the automatic orienting of attention in schizophrenic patients.

  1993cited by this paper
• Attentional asymmetry in schizophrenia: controlled and automatic processes.

  1992cited by this paper
• Visual orienting in schizophrenia.

  1992cited by this paper
• Disengagement of attention in chronic schizophrenia.

  1992cited by this paper
• Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.

  1992cited by this paper
• The chiral forms of ketamine as probes for NMDA receptor functions in humans

  1991cited by this paper
• Disengagement of attention in schizophrenia.

  1991cited by this paper
• Recent advances in the phencyclidine model of schizophrenia.

  1991cited by this paper
• NMDA receptor related agents : biochemistry, pharmacology and behavior

  1991cited by this paper
• Saccade preparation inhibits reorienting to recently attended locations.

  1989cited by this paper
• Scale for the Assessment of Negative Symptoms (SANS)*

  1989cited by this paper
• Psychotogenic drugs as models for schizophrenia.

  1988cited by this paper
• Asymmetries in hemispheric control of attention in schizophrenia.

  1988cited by this paper
• Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence.

  1986cited by this paper
• Eye movement dysfunctions and psychosis.

  1985cited by this paper
• Components of visual orienting

  1984cited by this paper
• Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.

  1980cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• Cognitive control as a transdiagnostic mechanism of action in psychedelic effects

  2025cites this paper
• Acute Effects and Long-Term Neuropsychological Consequences of Classic Psychedelics Use.

  2025cites this paper
• Human neuroimaging: fMRI.

  2025cites this paper
• Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors

  2024cites this paper
• Hemispheric annealing and lateralization under psychedelics (HEALS): A novel hypothesis of psychedelic action in the brain

  2024cites this paper
• Clinically relevant acute subjective effects of psychedelics beyond mystical experience

  2024cites this paper
• Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis

  2024cites this paper
• [Neuroimaging correlates of classical psychedelics effects: A systematic review].

  2024cites this paper
• On the advances in machine learning and complex network measures to an EEG dataset from DMT experiments

  2024cites this paper
• The Hallucinogen Rating Scale: Updated Factor Structure in a Large, Multistudy Sample

  2024cites this paper
• A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers

  2023cites this paper
• Pharmacological, Neural, and Psychological Mechanisms underlying Psychedelics: A Critical Review.

  2022cites this paper
• The Altered States Database: Psychometric data from a systematic literature review

  2022cites this paper
• Application of machine learning and complex network measures to an EEG dataset from DMT experiments

  2022cites this paper
• Psychedelic Cognition—The Unreached Frontier of Psychedelic Science

  2022cites this paper
• Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

  2021cites this paper
• Models of psychedelic drug action: modulation of cortical-subcortical circuits.

  2021cites this paper
• Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective

  2021cites this paper
• Early and Contemporary Human Neuroimaging Studies of Serotonergic Psychedelics

  2020cites this paper
• Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention

  2020cites this paper
• Altered states phenomena induced by visual flicker light stimulation

  2020cites this paper
• Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition

  2018cites this paper
• Glutamatergic Deficits in Schizophrenia – Biomarkers and Pharmacological Interventions within the Ketamine Model

  2018influential citation
• N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function

  2018cites this paper
• Chronic Ketamine Exposure Causes White Matter Microstructural Abnormalities in Adolescent Cynomolgus Monkeys

  2017cites this paper
• Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies

  2017cites this paper
• eview europharmacology of N , N-dimethyltryptamine heresa

  2016cites this paper
• Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.

  2016influential citation
• Clinical applications of hallucinogens: A review.

  2016cites this paper
• The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging

  2016cites this paper
• Neuropharmacology of N,N-dimethyltryptamine.

  2016cites this paper
• Imaging the effects of ketamine use and abuse in the brain

  2015cites this paper
• Ketamine-Induced Hallucinations

  2015cites this paper
• Psychedelics, glutamate, and neuroimaging studies.

  2014cites this paper
• Hypoxia-inducible Factors Are Already “Active” in the Von Hippel-Lindau– deficient Renal Cell Carcinoma-4 Cells

  2014cites this paper
• Ketamine: an update on its abuse.

  2014cites this paper
• The contribution of the brain response to ketamine to understanding the glutamatergic system and its role in human cognition

  2013cites this paper
• Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users

  2013cites this paper
• Auditory orienting and inhibition of return in schizophrenia: a functional magnetic resonance imaging study.

  2012cites this paper
• On the measurement of the effects of alcohol and illicit substances on inhibition of return

  2012influential citation
• Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency

  2012cites this paper
• Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers

  2012cites this paper
• N-methyl-D-aspartate receptor 2B subunit (GRIN2B) gene variation is associated with alerting, but not with orienting and conflicting in the Attention Network Test.

  2012cites this paper
• A mood disorder episode with an onset under chronic cannabis consumption and accompanied with psychotic features immediately after N, N-Dimethyltryptamine (DMT) use: a case report -

  2011cites this paper
• Esrar Kullanımı Sırasında Başlayan ve N, N- Dimetiltriptamin (Dmt) Kullanımı ile Psikotik Özellikler Eklenen Duygudurum Bozukluğu: Bir Olgu Sunumu / A Mood Disorder Episode with an Onset Under Chronic Cannabis Consumption, and Accompanied With Psychotic Features Immediately After N,N-Dimethyltryptam

  2011cites this paper
• Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

  2010cites this paper
• Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention

  2010cites this paper
• Glutamatergic Approaches to the Conceptualization and Treatment of Schizophrenia

  2009cites this paper
• Current awareness in human psychopharmacology

  2009cites this paper
• When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor

  2009cites this paper
• Temporal Dynamics of the Attentional Spotlight: Neuronal Correlates of Attentional Capture and Inhibition of Return in Early Visual Cortex

  2007cites this paper
• ELECTIVE POTENTIATION OF THE METABOTROPIC GLUTAMATE ECEPTOR SUBTYPE 2 BLOCKS PHENCYCLIDINE-INDUCED YPERLOCOMOTION AND BRAIN ACTIVATION

  year unknowncites this paper